Literature DB >> 6946728

Serious infections during continuing treatment of acute lymphoblastic leukaemia.

J Ninane, J M Chessells.   

Abstract

Seventy-six of 168 children with acute lymphoblastic leukaemia, who had completed induction therapy and central nervous system prophylaxis, were each admitted to hospital at least once during subsequent treatment with an infectious illness. The time spent in hospital was calculated as a proportion of the total number of days at risk and had a mean value of one day in 75. Sixty-three (37%) children spent longer than this in hospital, particularly patients younger than 5 years and those on a more intensive protocol; a third year of treatment appeared to carry no significant addition risk of infection. Death due to infection occurred in 14 (8.3%) children; these deaths were more common in younger patients and during the first 2 years of treatment and were mainly due to measles, septicaemia, or cytomegalovirus. These findings show that younger children and those receiving more intensive treatment are at greater risk of infection. The risk is not one of exotic infections, but of measles, a preventable disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6946728      PMCID: PMC1627408          DOI: 10.1136/adc.56.11.841

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Editorial: Treatment of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes
Journal:  N Engl J Med       Date:  1976-09-23       Impact factor: 91.245

2.  Protection against varicella in family contacts by immediate inoculation with live varicella vaccine.

Authors:  Y Asano; H Nakayama; T Yazaki; R Kato; S Hirose
Journal:  Pediatrics       Date:  1977-01       Impact factor: 7.124

3.  Attenuated measles vaccine in children with acute leukemia.

Authors:  A MITUS; A HOLLOWAY; A E EVANS; J F ENDERS
Journal:  Am J Dis Child       Date:  1962-03

4.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

5.  Fatalities during remission of childhood leukemia.

Authors:  J V Simone; E Holland; W Johnson
Journal:  Blood       Date:  1972-06       Impact factor: 22.113

6.  Pneumonia during therapy for childhood acute lymphoblastic leukemia.

Authors:  S E Siegel; M E Nesbit; R Baehner; H Sather; G D Hammond
Journal:  Am J Dis Child       Date:  1980-01

7.  Role of infection in the death of children with acute lymphoblastic leukaemia.

Authors:  A W Craft; M M Reid; E Bruce; J Kernahan; P S Gardner
Journal:  Arch Dis Child       Date:  1977-10       Impact factor: 3.791

8.  Atypical measles infections in leukaemic children on immunosuppressive treatment.

Authors:  C R Pullan; T C Noble; D J Scott; K Wisniewsk; P S Gardner
Journal:  Br Med J       Date:  1976-06-26

9.  Acute lymphoblastic leukaemia in children: Classification and prognosis.

Authors:  J M Chessells; R M Hardisty; N T Rapson; M F Greaves
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

10.  Analysis of treatment of childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiation.

Authors:  I C MacLennan; J Peto; H E Kay
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640

View more
  7 in total

1.  Measles in children who have malignant disease.

Authors:  J Kernahan; J McQuillin; A W Craft
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-04

2.  Remission death in acute lymphoblastic leukaemia: a changing pattern.

Authors:  A Atra; S M Richards; J M Chessells
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

3.  Risks and benefits of intensive treatment of acute leukaemia.

Authors:  J M Chessells
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

4.  Prognosis of Down's syndrome with acute leukaemia.

Authors:  G A Levitt; C A Stiller; J M Chessells
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

5.  Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukaemia.

Authors:  I Hughes; M E Jenney; R W Newton; D J Morris; P E Klapper
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

6.  Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.

Authors:  J M Chessells; A D Leiper; K Tiedemann; R M Hardisty; S Richards
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

7.  Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment.

Authors:  Claudia Bettoni da Cunha-Riehm; Verena Hildebrand; Michaela Nathrath; Markus Metzler; Meinolf Suttorp
Journal:  Front Immunol       Date:  2020-04-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.